Ming Y - Search Results

1

Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer.

Fu X, Zhang Y, Yang J, Qi Y, Ming Y, Sun M, Shang Y, Yang Y, Zhu X, Gao Q. Fu X, et al. Among authors: ming y. Onco Targets Ther. 2018 Sep 20;11:6091-6100. doi: 10.2147/OTT.S174138. eCollection 2018. Onco Targets Ther. 2018. PMID: 30275713 Free PMC article.

2

The Immunostimulative Effect and Mechanisms of a Novel Mouse Anti-Human PD-1 Monoclonal Antibody on Jurkat Lymphocytic Cells Cocultured with Hepatoma Cells.

Li Z, Li B, Li L, Wang G, Li Y, Fu R, Ming Y, Ni R, Wang J, Ye G, Chen J. Li Z, et al. Among authors: ming y. Onco Targets Ther. 2020 Nov 27;13:12225-12241. doi: 10.2147/OTT.S281397. eCollection 2020. Onco Targets Ther. 2020. PMID: 33273828 Free PMC article.

3

Saikosaponin D inhibits autophagosome‑lysosome fusion and induces autophagy‑independent apoptosis in MDA‑MB‑231 breast cancer cells.

Fu R, Zhang L, Li Y, Li B, Ming Y, Li Z, Xing H, Chen J. Fu R, et al. Among authors: ming y. Mol Med Rep. 2020 Aug;22(2):1026-1034. doi: 10.3892/mmr.2020.11155. Epub 2020 May 18. Mol Med Rep. 2020. PMID: 32468000 Free PMC article.

4

Cyclovirobuxine D Induces Apoptosis and Mitochondrial Damage in Glioblastoma Cells Through ROS-Mediated Mitochondrial Translocation of Cofilin.

Zhang L, Fu R, Duan D, Li Z, Li B, Ming Y, Li L, Ni R, Chen J. Zhang L, et al. Among authors: ming y. Front Oncol. 2021 Mar 19;11:656184. doi: 10.3389/fonc.2021.656184. eCollection 2021. Front Oncol. 2021. PMID: 33816313 Free PMC article.

5

Bovine Serum Albumin Nanoparticle-Mediated Delivery of Sorafenib for Improving Hepatocellular Carcinoma Therapy.

Ming Y, Li B, Fu R, Xing H, Liu Y, Duan D, Li Z, Li L, Ni R, Xu J, Li C, Xiang M, Song H, Chen J. Ming Y, et al. J Nanosci Nanotechnol. 2021 Oct 1;21(10):5075-5082. doi: 10.1166/jnn.2021.19362. J Nanosci Nanotechnol. 2021. PMID: 33875093

6

The Application of Peptides in Glioma: A Novel Tool for Therapy.

Li L, Chen J, Ming Y, Li B, Fu R, Duan D, Li Z, Ni R, Wang X, Zhou Y, Zhang L. Li L, et al. Among authors: ming y. Curr Pharm Biotechnol. 2022;23(5):620-633. doi: 10.2174/1389201022666210628114042. Curr Pharm Biotechnol. 2022. PMID: 34182908 Review.

7

Specific cancer stem cell-therapy by albumin nanoparticles functionalized with CD44-mediated targeting.

Li Y, Shi S, Ming Y, Wang L, Li C, Luo M, Li Z, Li B, Chen J. Li Y, et al. Among authors: ming y. J Nanobiotechnology. 2018 Dec 1;16(1):99. doi: 10.1186/s12951-018-0424-4. J Nanobiotechnology. 2018. PMID: 30501644 Free PMC article.

8

Recent Developments in Pharmacological Effect, Mechanism and Application Prospect of Diazeniumdiolates.

Li B, Ming Y, Liu Y, Xing H, Fu R, Li Z, Ni R, Li L, Duan D, Xu J, Li C, Xiang M, Song H, Chen J. Li B, et al. Among authors: ming y. Front Pharmacol. 2020 Jun 23;11:923. doi: 10.3389/fphar.2020.00923. eCollection 2020. Front Pharmacol. 2020. PMID: 32655397 Free PMC article. Review.

9

Dual-modified PCL-PEG nanoparticles for improved targeting and therapeutic efficacy of docetaxel against colorectal cancer.

Ni R, Duan D, Li B, Li Z, Li L, Ming Y, Wang X, Chen J. Ni R, et al. Among authors: ming y. Pharm Dev Technol. 2021 Oct;26(8):910-921. doi: 10.1080/10837450.2021.1957930. Epub 2021 Aug 1. Pharm Dev Technol. 2021. PMID: 34280065

10

Ascorbyl palmitate-incorporated paclitaxel-loaded composite nanoparticles for synergistic anti-tumoral therapy.

Zhou M, Li X, Li Y, Yao Q, Ming Y, Li Z, Lu L, Shi S. Zhou M, et al. Among authors: ming y. Drug Deliv. 2017 Nov;24(1):1230-1242. doi: 10.1080/10717544.2017.1370619. Drug Deliv. 2017. PMID: 28856937 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,063 results

Search Page

Filters